Latest 5 articles from heartwire
- Psoriasis "firmly established" as risk factor for CV disease
Mar 14, 2010 10:15 EDT - No increased atherosclerotic-plaque burden in cops and firefighters
Mar 14, 2010 08:45 EDT - Nanoparticle detonations may be able to burn vascular plaques
Mar 14, 2010 08:15 EDT - ACCORD BP: Intensive BP lowering futile in diabetics
Mar 14, 2010 08:00 EDT - ACCORD: Fenofibrate no benefit to statin therapy in high-risk diabetic patients
Mar 14, 2010 08:00 EDT
Reflections on 25 years of cardiology meetings: Where do we go for "live" scientific exchange?
Posted Dec 03, 2008
at 09:42 AM, EDT
by Eric Topol
Back in the 1980s abstract presentations were a core part of our cardiology meetings, a crowded place where science was presented and hotly debated amongst peers. Why are these presentations now so poorly attended? Has the way information is disseminated affected how we interact at meetings and what we expect from them? Where do we now go for “live” scientific exchange? What are your thoughts? How do you feel the meetings have evolved over the years? What form will they take in the future?
Previous postsBillets précédents
Mobile pocket echo device: Revolutionizing medicine
32 comments32 commentaires |
Posted Feb 05, 2010
at 12:40 PM, EDT by Eric Publié le 02.05.2010 à 12h40 par Eric
at 12:40 PM, EDT by Eric Publié le 02.05.2010 à 12h40 par Eric
Lipoprotein(a): a causal factor for coronary disease
3 comments3 commentaires |
Posted Jan 07, 2010
at 10:30 AM, EDT by Eric Publié le 01.07.2010 à 10h30 par Eric
at 10:30 AM, EDT by Eric Publié le 01.07.2010 à 10h30 par Eric
Twitter: A place in the medical world?
5 comments5 commentaires |
Posted Dec 16, 2009
at 10:30 AM, EDT by Eric Publié le 12.16.2009 à 10h30 par Eric
at 10:30 AM, EDT by Eric Publié le 12.16.2009 à 10h30 par Eric
PACE: A trial that challenges dogma
No commentsAucun commentaire |
Posted Nov 24, 2009
at 01:50 PM, EDT by Eric Publié le 11.24.2009 à 13h50 par Eric
at 01:50 PM, EDT by Eric Publié le 11.24.2009 à 13h50 par Eric
Ezetimibe in ARBITER 6-HALTS: What lessons can we learn?
3 comments3 commentaires |
Posted Nov 16, 2009
at 05:00 PM, EDT by Eric Publié le 11.16.2009 à 17h00 par Eric
at 05:00 PM, EDT by Eric Publié le 11.16.2009 à 17h00 par Eric
Also from theheart.org
Blogs I read
Who's talking
|
Eric J Topol MD
Director, Scripps Translational Science Institute The Gary and Mary West Chair of Innovative Medicine Chief Academic Officer, Scripps Health La Jolla, CA |














CommentsCommentaires
I fully agree with your comments regarding meetings. My impression, though, is that the attendance to meetings of all kinds has decreased in a progressive manner during the last 3-4 years. I have been organizing a meeting in Spain for 20 consecutive years, the Madrid Arrhythmia Meeting. It initially had a great success with an attendance of up to 1100 people that for a meeting of this kind was a lot. RF ablation was at its inception when we began back in 1988 and the ICD was on its rise. There was a great interest but also at that time it was difficult and expensive to have access to the latest information. We had no internet and the time lag for publication frequently extended over one year since you presented your work as an abstract until it finally reached the printed status in a journal. And last, but not least, you had to go to the library to get a photocopy of the paper to read and study its content. From 2000 onwards the Internet has become universally available. The Internet has brought the library to our offices and homes. We file on our disks the original papers in a few seconds. And the publication process has been speeded up making the papers available to the Internet audience well before their appearance in the printed version of the journals that by the way few people utilize today as a source of study. And when a new important presentation of a trial is presented at a meeting it is possible to obtain detailed information of it, even with comments from various sources, through internet portals such as theheart.org, medscape etc. Travelling has become expensive, inconvenient, and the chances for finding sponsorship are more and more difficult for economic but also for ethical reasons. The economic impact is not only related to the expenses incurred to attend the meeting but also in the money that practicing cardiologist would not earn during their leave period to attend a congress. When you balance what you get against what you lose having other alternatives to keep informed, the final result is what we are seeing: the attendance to meetings is shrinking! An additional factor that I have found at least in my country, Spain, is that the younger generations of cardiologists are much more actively involved in the sharing of familial responsibilities and tasks with their couples and that stimulates to limit the attendance to meetings, again taking into consideration that there are other alternatives to maintain a good information level.
In fact I believe that the Internet represents the key issue as the invention of the Gutenberg press did in the 15th century. I do not know if it realistic to try to see how can we get more people attending to the Abstracts sessions, when we should probably develop Internet-based abstract presentations admitting comments (like you are doing here) that would be selected by the chairpersons and answered by the authors and maintained for at least one year in the web.
Jerónimo Farré MD, PhD, FESC
Then there is the investment community, stock analysts, fund managers, etc. who are looking for the next big thing, or who are monitoring current trials to get the news before their competitors. If one were to watch some of the closed-circuit broadcasts from the exhibit floor, you might think you were at a football or soccer match, when the sales team cheers positive results for their product.
Can you imagine if Andreas Gruentzig were to present his modest abstract on this odd procedure he called angioplasty in the current meeting environment? Would interventional cardiology have survived the instant amplification of results?
How to present and exchange scientific information and have the freedom to show results of early stage experiments, how to look for professional feedback without the entire process being corrupted by the enlarged eye of the media/financial world is indeed a complex question -- definitely a case of the Heisenberg principle -- where the effect of the observer on the observed is inversely proportional to the mass of the observed object. In other words, small, embryonic concepts presented in abstracts and poster presentations are highly susceptible to alteration by the external forces I've described.
Hi Eric, thought provoking and insightful as usual. I guess it will be harder every year to maintain "megameetings" with the current wealth of info available through the internet and the sub-subspecialization of cardiology. However, in my view one of the major drawbacks of how most meetings are currently organized is the almost total lack of participation by the audience in any meaningful way (... please, ... spare me those phony "select your option" question and answer sessions .. who are we kidding ...) not only at the abstract sessions but, why not, at plenary sessions also (less time to talk or fewer speakers, more time for the audience, how about that?). Nobody can ask ANY questions, ever. Smaller meetings, informal but paradoxically sometimes more scientifically sound, may also be a lot more fun and educational. Arguments and even heated discussions are good for science ... could it be that they are not as good for sponsors ... hoops, I am sorry I said that ... allright i'll take it back ... I also feel that the "external forces" have gone a little too far, making more people of the medical community somewhat skeptical about what they hear at megameetings.
Eric,
Thanks for these comments and for bringing this important observation to the forefront. I fully agree with your concerns about attendance at the abstract sessions and think that it might be a function of total sensory overload. I suggest that consideration be given to reformatting these meetings so that we interdigitate original research sessions with general or disease-focussed sessions, e.g. part of the day be more oriented to original research and the rest of the day to general or disease-specific session ratherthan both all the time? Another model would be to "frontload", "backload" or even "interdigitate" relevant new original reserach into particular theme. I quite like the latter.... I look forward to your thoughts.